Cue Health 2023 Investor Presentation

Cue Health presents its 2023 investor deck highlighting its COVID-19 diagnostic platform achievements, including $200M+ peak revenue and expansion into respiratory care and sexual health testing. The company details FDA authorizations, cost restructuring plans targeting $150M in annual savings, and its integrated care platform spanning POC diagnostics, telehealth, and at-home testing kits serving a $30B+ addressable market.